Murphy & Mullick Capital Management Corp

Position in RDY — Dr Reddys Laboratories Ltd

CIK 2047271 SMITHTOWN, NY

Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,735

+$960 QoQ

Shares Held

1,500

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#191

of 238 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Murphy & Mullick Capital Management Corp holds $36,797 across 6 Drug Manufacturers - Specialty & Generic names. RDY ranks #1 (59.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd This page	1,500	$21,735
2	ELAN	Elanco Animal Health Inc	500	$12,305
3	VTRS	Viatris Inc	85	$1,349
4	ZTS	Zoetis Inc.	14	$1,006
5	TLRY	Tilray Brands, Inc.	58	$260
6	CGC	Canopy Growth Corp	150	$142

All Filings in RDY

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,735	1,500	0.0%	Shares	Sole	2026-08-14
2026-03-31	$20,775	1,500	0.0%	Shares	Sole	2026-04-17
2025-12-31	$21,060	1,500	0.0%	Shares	Sole	2026-02-10
2025-09-30	$20,970	1,500	0.0%	Shares	Sole	2025-11-07
2025-06-30	$22,545	1,500	0.0%	Shares	Sole	2025-08-14
2025-03-31	$19,785	1,500	0.0%	Shares	Sole	2025-05-14
2024-12-31	$23,685	1,500	—	Shares	Sole	2025-02-12
No filing history on record for this holder in this stock.